In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...

The recent dismissal of 13 FDA review staff eliminated precisely the kind of government spending that delivered the most bang ...

The president said that, because of his executive order, prescription drug prices would be cut “almost immediately.” Here's ...

Trump gives the impression that Americans will shortly see steep decreases in what they pay for prescription drugs. But even ...

A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic ...

But regulation of drug development begins long before the approval ... Although the approval process for generic drugs—medicines made by third parties after patent exclusivity has expired ...

CivicaRx is a nonprofit generic drug company formed by hospitals and ... that cannot be invested in American manufacturing or the development of future treatments and cures for patients," said ...

Tariffs, compounded by existing drug shortages, could increase costs for medications in the U.S. Many, or all, of the products featured on this page are from our advertising partners who ...

Generic drug makers, with slim profit margins ... That may force them to cut costs in other areas, especially research and development, potentially slowing future innovation.